Background illustration for clinical trials search

Stem Cells Clinical Trials

Find clinical trials for stem cells. Search for stem cells clinical trials in different cities and states across the United States.

Filter

A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant

for
Graft Versus Host Disease, Graft Vs Host Disease,
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07006506

Phase 2, Recruiting

Anterior Cruciate Ligament (ACL) Reconstruction With Autologous Fat Pad Derived Mesenchymal Stem Cells

for
Anterior Cruciate Ligament Reconstruction
Location: Houston TX
Sponsor: The Methodist Hospital Research Institute

Sex: All

Age: 18+

Code: NCT06798623

Phase 1, Recruiting

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

for
AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL),
Location: Boston MA, New York NY, Charlottesville VA,
Sponsor: Center for International Blood and Marrow Transplant Research

Sex: All

Age: 18 - 66

Code: NCT06859424

Phase 2, Recruiting

Improvement of Women's Health After Allogeneic Stem Cell Transplantation

for
GVHD, Chronic
Location: Montreal
Sponsor: Ciusss de L'Est de l'Île de Montréal

Sex: Female

Age: 18+

Code: NCT06279676

Recruiting

Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity

for
Lymphoproliferative Disorders, Autoimmune Lymphoproliferative,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 4 - 69

Code: NCT04339777

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury

for
Traumatic Brain Injury
Location: Houston TX, San Antonio TX
Sponsor: Hope Biosciences LLC

Sex: All

Age: 18 - 55

Code: NCT05951777

Phase 2, Recruiting

Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation

for
Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT06138587

Phase 1, Recruiting

Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma

for
NK-Cell Lymphoma, NK-Cell Leukemia, Peripheral T Cell Lymphoma
Location: Valhalla NY, Columbus OH, Grand Rapids MI,
Sponsor: New York Medical College

Sex: All

Age: 1 - 31

Code: NCT03719105

Early Phase 1, Recruiting

Busulfan, Melphalan, Escalating Carfilzomib Conditioning Auto Stem Cell Transplantation for Multiple Myeloma (MM)

for
Multiple Myeloma
Location: Maywood IL
Sponsor: Loyola University

Sex: All

Age: 18+

Code: NCT03795597

Phase 1, Phase 2, Recruiting

Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma

for
Hodgkin Lymphoma
Location: St. John's, Halifax, Sherbrooke, Montreal, Ottawa,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT05180097

Phase 2, Recruiting

Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Treating Pediatric Patients With Positive Cytomegalovirus Undergoing Donor Stem Cell Transplant

for
Cytomegaloviral Infection,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 1 - 21

Code: NCT03354728

Phase 1, Phase 2, Recruiting

A Trial Comparing Single Agent Melphalan to Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) as a Preparative Regimen for Patients With Multiple Myeloma Undergoing High Dose Therapy Followed by Autologous Stem Cell Reinfusion

for
Multiple Myeloma
Location: Seattle WA
Sponsor: Swedish Medical Center

Sex: All

Age: 18 - 70

Code: NCT03570983

Phase 2, Recruiting

SCD Stem Cell Mobilization and Apheresis Using Motixafortide

for
Sickle Cell Disease
Location: Bethesda MD, Birmingham AL, Memphis TN
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 18+

Code: NCT06442761

Phase 1, Recruiting

Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis

for
Systemic Sclerosis, Diffuse Sclerosis Systemic,
Location: Pittsburgh PA
Sponsor: Paul Szabolcs

Sex: All

Age: 8 - 60

Code: NCT03630211

Phase 2, Recruiting

Human Mesenchymal Stem Cells (hMSC) in Behavioral Problems Due to Alzheimer's Disease.

for
Alzheimer Disease, Agitation in Dementia
Location: Miami FL
Sponsor: Bernard (Barry) Baumel

Sex: All

Age: 55 - 70+

Code: NCT06781333

Phase 2, Recruiting

Characterization of T-cell Repertoire in Patients With Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant

for
Acute Myeloid Leukemia
Location: Los Angeles CA
Sponsor: University of Southern California

Sex: All

Age: 18+

Code: NCT03921047

Recruiting

Acute Myeloid Leukemia and Markers of Leukemia Stem Cells (CLL1 and CD45RA)

for
Acute Myeloid Leukemia
Location: Stony Brook NY
Sponsor: Suhu Liu

Sex: All

Age: 18+

Code: NCT06297551

Recruiting

Stem Cell Mobilization by G-CSF Post Myocardial Infarction to Promote Myocyte Repair

for
Myocardial Infarction
Location: Ottawa
Sponsor: University of Ottawa

Sex: All

Age: 40 - 70+

Code: NCT00394498

Phase 2, Phase 3, Recruiting

Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same Donor

for
SIOD, Cystinosis, FSGS, SLE Nephritis, CKD Stage 4
Location: Palo Alto CA
Sponsor: Alice Bertaina

Sex: All

Age: 1 - 30

Code: NCT05508009

Phase 1, Phase 2, Recruiting

A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell Transplant

for
Graft Vs Host Disease, Graft-versus-host-disease
Location: San Francisco CA
Sponsor: Christopher Dvorak

Sex: All

Age: 0 - 30

Code: NCT04337515

Recruiting

What stem cell therapy clinical trials are studying now

Transplants for blood cancers and blood disorders. Hematopoietic stem cell transplant replaces a person's blood forming system with their own stored cells or a donor's. Trials test safer conditioning, better donor matching, including half matched family donors for sickle cell disease, and ways to prevent graft versus host disease.

Transplants for autoimmune disease. Resetting the immune system with a person's own stem cells is being tested against the best available drugs in relapsing multiple sclerosis, in a Phase 3 trial funded by the National Institutes of Health at more than 20 US sites.

Mesenchymal stromal cells. Cells from bone marrow or fat that calm inflammation, tested for Crohn's disease, graft versus host disease, and hard to heal wounds. The first one was approved in 2024 after decades of trials.

Cells made from stem cells. Lab grown dopamine neurons for Parkinson's disease and insulin producing islet cells for type 1 diabetes, both now in or entering late stage trials.

Gene corrected stem cells. A person's own blood stem cells are edited to fix a mutation and returned. Two such therapies for sickle cell disease were approved in 2023; see gene therapy clinical trials. Immune cell therapies such as CAR T are a different technology, covered on our CAR T cell therapy page.

Stem cell transplants are part of care for leukemia, lymphoma, and multiple myeloma; each page lists its own studies.

Article preview image

New to research? Read how informed consent works.

Informed Consent in Clinical Trials: What Is It and How It’s Obtained

Who can participate in stem cell therapy clinical trials?

Is stem cell therapy safe?

How long does stem cell therapy last?

Do stem cell trial participants get paid?

How to enroll in a stem cell clinical trial